Do we have a knowledge transfer and translation plan at Teratogen Information Services?
Recently, a new field in science is emerging, which addresses the issue of ensuring that information that is generated from research, reaches the right people in the right format. This has been coined as knowledge transfer and translation and public health leaders worldwide are finding out ways to carry this out effectively. Ultimately, this should ensure greater investment in knowledge syntheses and transfer initiatives, that involve potential users of research to improve the quality of health for everyone. In this brief review/comment, an attempt will be made to help the readers understand the meaning of this new terminology and how it impacts Teratogen Information Services.
Einarson
Adrienne
A
The Motherisk Program, Population Health Sciences, Division of Clinical Pharmacology, The Hospital for Sick Children, The University of Toronto, 555 University Avenue, Toronto, Ont., Canada M5G 1X8. einarson@sickkids.on.ca
Lockett
Donna
D
D002170:Canada; D004346:Drug Information Services; D007722:Health Knowledge, Attitudes, Practice; D006801:Humans; D033181:Information Dissemination; D013723:Teratogens / Q000633:toxicity*
D013723:Teratogens